| |
Male
|
Female
|
|---|
|
Fracture
|
Controls Osteoarthritis
|
Fracture
|
Controls Osteoarthritis
|
|---|
|
Number of subjects
|
21
|
25
|
49
|
15
|
|
Age (years)
|
77.3 ± 9,1a
|
64.3 ± 10.9
|
77.3 ± 11.0
|
68.0 ± 7.9
|
|
Height (cm)
|
174.0 ± 7.0
|
176.0 ± 5.1
|
161.9 ± 6.9
|
162.9 ± 7.5
|
|
Weight (kg)
|
75.9 ± 15.0 b
|
89.7 ± 11.5
|
68.7 ± 15.9
|
79.0 ± 18.0
|
|
Prevalent fracture (No.)
|
2
|
0
|
21 a
|
0
|
|
Glucocorticoids (No.)
|
1
|
0
|
6
|
1
|
|
Smoking (No.)
|
2
|
2
|
5
|
1
|
|
Diabetes (No.)
|
3
|
6
|
11
|
3
|
|
Creatinine (μmol/l)
|
107 ± 33.9
|
97.6 ± 21.7
|
90.9 ± 29.1
|
79.6 ± 9.1
|
|
Bone pentosidine (nmol/g dry bone mass) c
|
2.96 a
|
1.10
|
2.57 a
|
0.93
|
|
0.55;6.80
|
0.41;2.41
|
0.75;5.11
|
0.45;1.98
|
|
Serum pentosidine (nmol/l) c
|
73.6 a
|
27.1
|
71.5 a
|
30.3
|
|
48.4; 417.4
|
15.46;80.3
|
31.4;154.6
|
16.2;108.0
|
- a:p < 0.001; b:p < 0.005; c:Median a 95 % CI
